Cost-benefit analysis of introducing next-generation sequencing (metagenomic) pathogen testing in the setting of pyrexia of unknown origin

Cost-benefit analysis of introducing next-generation sequencing (metagenomic) pathogen testing in the setting of pyrexia of unknown origin

10.1371/journal.pone.0194648

Saved in:

書目詳細資料
Main Authors:	Chai J.H., Lee C.K., Lee H.K., Wong N., Teo K., Tan C.S., Thokala P., Tang J.W.-T., Tambyah P.A., Oh V.M.S., Loh T.P., Yoong J.
其他作者:	CENTRE FOR MOLECULAR EPIDEMIOLOGY
格式:	Article
出版:	2019
主題:	Article cost benefit analysis decision making diagnostic cost diagnostic test diagnostic value feasibility study health care system health economics human metagenomics next generation sequencing probability pyrexia idiopathica sensitivity analysis Singapore bacterium economics fever genetics high throughput sequencing microbiology Bacteria Cost-Benefit Analysis Fever High-Throughput Nucleotide Sequencing Humans Metagenomics
在線閱讀:	https://scholarbank.nus.edu.sg/handle/10635/161234
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!
機構:	National University of Singapore

實物特徵
總結:	10.1371/journal.pone.0194648